As Yun Mao, vice president, Drug Product Development, explains, the team’s work helps bridge the gap between a promising molecule and a medicine patients can use seamlessly. Her team turns scientific discoveries into medicines designed with patients in mind, considering not only efficacy and safety, but the overall treatment experience.
“Our goal is not only to develop effective medicines. It’s to develop medicines that fit into the context of patients’ lives. That’s what patient-driven product design means for us.”
Patient insights play an important role in that process. Through co-creation with patient advocacy organizations and learning from patient testimonials, our teams seek to understand challenges that may influence how people experience treatment. Those insights help inform decisions about formulation, administration, and delivery technologies.
“When we talk with patients, we often hear they want a sense of normalcy. They want treatment to fit into their lives, not to organize their lives around it. That shapes decisions we make in the lab, from how many tablets someone takes to how a medicine is administered.”
Small changes can make a big difference
Patient-driven product design isn’t always about a breakthrough scientific discovery. Sometimes, it means making thoughtful changes that help treatment fit more easily into daily life.
That can take many forms. Scientists may reformulate a medicine to reduce the number of tablets a patient takes each day, helping simplify treatment routines. Teams may also develop innovative dosage forms, such as mini-tablets that can be mixed with food or tablets designed to dissolve on the tongue, to address the needs of patients who have difficulty swallowing. They also consider how medicines fit into daily routines, including the foods that may be familiar and accessible across different cultures or regions.
Packaging is another important part of the treatment experience. Teams consider whether it is easy to open for someone with limited hand strength and whether it works with the way patients organize their medicines each week.
Teams also explore administration approaches that may reduce the time patients spend receiving treatment or offer greater flexibility in how and where it is administered. Together, these choices reflect a broader goal: reducing barriers that can make treatment more difficult to manage.
For patients like Jennifer, that flexibility can mean spending less time thinking about treatment and more time focused on work, family, and daily routines. What may seem like a small design decision in the laboratory can meaningfully shape how treatment is experienced in everyday life.
What innovation looks like to a patient
For Jennifer, innovation isn’t measured in scientific terms. It’s measured in moments.
Being able to show up for her son. Continuing to build a career she loves. Spending time in her garden. Returning to activities like hot yoga. Planning for the future instead of being defined by her disease.